
Levecad 500 Tablet
Marketer
Cadila Pharmaceuticals Ltd
Salt Composition
Levetiracetam (500mg)
Overview Levecad 500 Tablet
Epileptic seizures are managed with the anticonvulsant Levecad 500mg tablets. This medication, effective both independently and in combination therapies, controls seizures through consistent usage. Levecad 500mg works by regulating abnormal brain electrical activity. Administer with or without food, maintaining a consistent daily schedule for optimal results. Dosage is personalized based on individual response and condition, determined by your physician. Typically prescribed for long-term management, continued use as directed is crucial; discontinuation or missed doses risk increased seizure frequency. Headache, irritability, drowsiness, altered behavior (including aggression), and reduced appetite are common, usually mild side effects, often diminishing after initial weeks. While most side effects are self-limiting, some require medical attention. Suicidal ideation has been reported in rare instances; contact your doctor immediately if experiencing mood deterioration. Prior to commencing treatment, disclose any pre-existing kidney issues, depressive symptoms, suicidal tendencies, or pregnancy/breastfeeding status. Regular blood tests may be recommended to monitor renal function during therapy.
Uses of Levecad 500 Tablet
Managing Epileptic Seizures
Major Benefits of Levecad 500 Tablet:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Levecad 500 Tablets can be consumed with or without food, although consistent timing is recommended.
Common Side effects of Levecad 500 Tablet:
- Sleepiness
- Dizziness
- Fatigue
- Headache
- Decreased appetite
- Behavioral changes
- Aggressive behavior
- Irritation
- Agitation
- Nasal congestion (stuffy nose)
- Infection
- Convulsion
- Nasopharyngitis (inflammation of the throat and nasal passages)
- Nausea
- Tremors
- Vertigo
- Lethargy
How to use Levecad 500 Tablet:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Levecad 500 Tablets can be consumed with or without food, although consistent timing is recommended.
How Levecad 500 Tablet works:
Levecad 500mg tablets are used to treat epilepsy. Their mechanism involves binding to SV2A receptors on neurons, thereby inhibiting excessive neuronal firing and preventing the propagation of seizure-inducing electrical impulses.
SAFETY ADVICE
AlcoholUNSAFE
Alcohol consumption alongside Levecad 500 Tablets is inadvisable.
PregnancySAFE IF PRESCRIBED
Pregnancy use of Levecad 500 Tablets is considered safe. Research largely indicates minimal to no developmental harm to the fetus.
Breast feedingSAFE IF PRESCRIBED
Using Levecad 500 Tablet while breastfeeding is likely safe. Available human data indicates minimal risk to the infant. Observe the infant for drowsiness and satisfactory weight increase.
DrivingUNSAFE
Taking Levecad 500 Tablets might reduce attentiveness, impair vision, or cause drowsiness and dizziness. Driving should be avoided if these side effects appear.
KidneyCAUTION
Patients with kidney impairment should exercise caution when using Levecad 500 Tablets, as dosage modification may be necessary. Physician consultation is advised.
LiverSAFE IF PRESCRIBED
Use of Levecad 500 Tablet in patients with liver disease is likely safe, with limited evidence suggesting dose modification isn't usually necessary. Consult your physician; however, a reduced dosage might be recommended for those with severe hepatic impairment.
What if you forget to take Levecad 500 Tablet :
Should you forget a Levecad 500 Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Levecad 500 Tablet
| Label | Value |
|---|---|
| Chemical Category | Pyrrolidinone-Acetamide Derivative |
| Developing Habits | No. |
| Treatment Category | Neuroscience of the Central Nervous System |
| Action Class | AED: A protein ligand bound to synaptic vesicle 2 |
